Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies
Smith, Tyler E, Madhavan, Maya, Gratch, Daniel, Patel, Aneek, Saha, Valerie, Sammarco, Carrie, Rimler, Zoe, Zuniga, Guadalupe, Gragui, Dunia, Charvet, Leigh, Cutter, Gary, Krupp, Lauren, Kister, Ilya, Ryerson, Lana Zhovtis
Published in Multiple sclerosis and related disorders (01.04.2022)
Published in Multiple sclerosis and related disorders (01.04.2022)
Get full text
Journal Article
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center
Parrotta, Erica, Kister, Ilya, Charvet, Leigh, Sammarco, Carrie, Saha, Valerie, Charlson, Robert Erik, Howard, Jonathan, Gutman, Josef Maxwell, Gottesman, Malcolm, Abou-Fayssal, Nada, Wolintz, Robyn, Keilson, Marshall, Fernandez-Carbonell, Cristina, Krupp, Lauren B, Zhovtis Ryerson, Lana
Published in Neurology : neuroimmunology & neuroinflammation (01.09.2020)
Published in Neurology : neuroimmunology & neuroinflammation (01.09.2020)
Get full text
Journal Article
Earlier Goals of Care Discussions in Hospitalized Terminally Ill Patients and the Quality of End-of-Life Care: A Retrospective Study
Gieniusz, Marzena, Nunes, Rosane, Saha, Valerie, Renson, Audrey, Schubert, Finn David, Carey, Jeanne
Published in American journal of hospice & palliative medicine (01.01.2018)
Published in American journal of hospice & palliative medicine (01.01.2018)
Get more information
Journal Article